| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |